Skip to main content
. 2020 May 8;55:102757. doi: 10.1016/j.ebiom.2020.102757

Table 2.

Prevalence of pfhrp2 and pfhrp3 deletions including in polyclonal infections in clinical samples.

DNA source Country pfhrp2 and/or pfhrp3 deletions in samples
pfhrp2/3 deletions in polyclonal infections
pfhrp2 n(%) pfhrp3 n(%) pfhp2/3 n%) pfhrp2 n(%) pfhrp3 n(%) pfhp2/3 n(%)
Eritrea Eritrea (n = 50) 0 10 (20) 31 (62) 3 (6) 4 (8) 0
MRL Djibouti (n = 1) 0 0 0 0 0 0
Kenya (n = 20) 0 0 0 1 (5) 1 (5) 0
Eritrea (n = 1) 0 0 0 0 0 1 (100)
Ethiopia (n = 2) 0 1 (50) 0 0 0 0
Somalia (n = 3) 0 0 0 0 (2) 66.7 0
South Sudan (n = 12) 0 3 (25) 0 1 (10) 0 0
Sudan (n = 29) 1 (3.5) 1 (3.5) 1 (3.5) 0 3 (10.3) 0
Tanzania (n = 16) 0 0 0 0 1 (6.3) 0
Uganda (n = 27) 0 1 (3.7) 0 2 (7.4) 3 (11.2) 0
East Africa (n = 2) 0 0 0 0 0 0
Kenya/Tanzania Kenya (n = 150) 0 0 0 5 (3.4) 0 0
Tanzania (n = 149) 1 (0.7) 1 (0.7) 0 1 (0.7) 0 0